| Nov 21, 2025 |
Nov 26, 2025 |
KalVista Pharmaceuticals, Inc.
|
CHIEF DEVELOPMENT OFFICER |
Sell |
42.5
|
-4,331
|
-1.90%
|
✗
|
$58.3K |
| Nov 17, 2025 |
Nov 19, 2025 |
KalVista Pharmaceuticals, Inc.
|
CHIEF DEVELOPMENT OFFICER |
Sell |
46.3
|
-2,683
|
-1.97%
|
✗
|
$38.8K |
| Aug 22, 2025 |
Aug 26, 2025 |
KalVista Pharmaceuticals, Inc.
|
CHIEF DEVELOPMENT OFFICER |
Sell |
46.3
|
-1,954
|
-1.46%
|
✗
|
$26.2K |
| Aug 21, 2025 |
Aug 25, 2025 |
KalVista Pharmaceuticals, Inc.
|
CHIEF DEVELOPMENT OFFICER |
Sell |
46.3
|
-2,362
|
-1.77%
|
✗
|
$31.2K |
| Aug 17, 2025 |
Aug 19, 2025 |
KalVista Pharmaceuticals, Inc.
|
CHIEF DEVELOPMENT OFFICER |
Sell |
46.3
|
-2,649
|
-2.00%
|
✗
|
$34.9K |
| Jul 8, 2025 |
Jul 10, 2025 |
KalVista Pharmaceuticals, Inc.
|
CHIEF DEVELOPMENT OFFICER |
Sell |
97.5
|
+29,750
|
30.30%
|
✗
|
$474.7K |
| May 22, 2025 |
May 27, 2025 |
KalVista Pharmaceuticals, Inc.
|
CHIEF DEVELOPMENT OFFICER |
Sell |
46.3
|
-1,926
|
-1.92%
|
✗
|
$21.8K |
| May 21, 2025 |
May 23, 2025 |
KalVista Pharmaceuticals, Inc.
|
CHIEF DEVELOPMENT OFFICER |
Sell |
46.3
|
-2,317
|
-2.33%
|
✗
|
$27.5K |
| May 17, 2025 |
May 20, 2025 |
KalVista Pharmaceuticals, Inc.
|
CHIEF DEVELOPMENT OFFICER |
Sell |
46.3
|
-2,600
|
-2.65%
|
✗
|
$30.8K |
| Feb 22, 2025 |
Feb 25, 2025 |
KalVista Pharmaceuticals, Inc.
|
CHIEF DEVELOPMENT OFFICER |
Sell |
46.3
|
-1,918
|
-2.00%
|
✗
|
$19.2K |
| Feb 17, 2025 |
Feb 19, 2025 |
KalVista Pharmaceuticals, Inc.
|
CHIEF DEVELOPMENT OFFICER |
Sell |
46.3
|
-2,601
|
-2.73%
|
✗
|
$25.6K |
| Nov 22, 2024 |
Nov 27, 2024 |
KalVista Pharmaceuticals, Inc.
|
CHIEF DEVELOPMENT OFFICER |
Sell |
46.3
|
-1,963
|
-2.11%
|
✗
|
$19.4K |
| Nov 17, 2024 |
Nov 19, 2024 |
KalVista Pharmaceuticals, Inc.
|
CHIEF DEVELOPMENT OFFICER |
Sell |
42.5
|
-7,192
|
-7.40%
|
✗
|
$66.6K |
| Aug 22, 2024 |
Aug 26, 2024 |
KalVista Pharmaceuticals, Inc.
|
CHIEF DEVELOPMENT OFFICER |
Sell |
46.3
|
-1,916
|
-2.19%
|
✗
|
$23.8K |
| Aug 17, 2024 |
Aug 21, 2024 |
KalVista Pharmaceuticals, Inc.
|
CHIEF DEVELOPMENT OFFICER |
Sell |
42.5
|
-7,102
|
-7.76%
|
✗
|
$85.3K |
| May 17, 2024 |
May 21, 2024 |
KalVista Pharmaceuticals, Inc.
|
CHIEF DEVELOPMENT OFFICER |
Sell |
42.5
|
-11,610
|
-12.66%
|
✗
|
$136.6K |
| Feb 17, 2024 |
Feb 21, 2024 |
KalVista Pharmaceuticals, Inc.
|
CHIEF DEVELOPMENT OFFICER |
Sell |
42.5
|
-12,053
|
-14.19%
|
✗
|
$170.1K |
| Feb 14, 2024 |
Feb 16, 2024 |
KalVista Pharmaceuticals, Inc.
|
CHIEF DEVELOPMENT OFFICER |
Sell |
40.0
|
-39,886
|
-37.61%
|
✗
|
$598.7K |
| Nov 17, 2023 |
Nov 21, 2023 |
KalVista Pharmaceuticals, Inc.
|
Chief Development Officer |
Sell |
42.5
|
-7,113
|
-13.38%
|
✗
|
$58.5K |
| Aug 17, 2023 |
Aug 21, 2023 |
KalVista Pharmaceuticals, Inc.
|
Chief Development Officer |
Sell |
42.5
|
-7,142
|
-14.63%
|
✗
|
$76.6K |
| May 17, 2023 |
May 19, 2023 |
KalVista Pharmaceuticals, Inc.
|
Chief Development Officer |
Sell |
46.3
|
-2,604
|
-6.52%
|
✗
|
$26.4K |
| Feb 17, 2023 |
Feb 23, 2023 |
KalVista Pharmaceuticals, Inc.
|
Chief Development Officer |
Sell |
46.3
|
-2,727
|
-7.09%
|
✗
|
$20.9K |
| Nov 17, 2022 |
Nov 21, 2022 |
KalVista Pharmaceuticals, Inc.
|
Chief Development Officer |
Sell |
47.5
|
-1,139
|
-3.22%
|
✗
|
$6.2K |
| Aug 17, 2022 |
Aug 19, 2022 |
KalVista Pharmaceuticals, Inc.
|
Chief Development Officer |
Sell |
46.3
|
-1,145
|
-3.30%
|
✗
|
$17.1K |
| Nov 1, 2021 |
Nov 3, 2021 |
KalVista Pharmaceuticals, Inc.
|
Chief Development Officer |
Sell |
25.0
|
-5,000
|
-13.17%
|
✓
|
$90.3K |
| Aug 2, 2021 |
Aug 4, 2021 |
KalVista Pharmaceuticals, Inc.
|
Chief Development Officer |
Sell |
25.0
|
-5,000
|
-11.64%
|
✓
|
$102.6K |
| May 3, 2021 |
May 6, 2021 |
KalVista Pharmaceuticals, Inc.
|
Chief Development Officer |
Sell |
25.0
|
-5,000
|
-10.42%
|
✓
|
$124.2K |
| Feb 23, 2021 |
Feb 25, 2021 |
KalVista Pharmaceuticals, Inc.
|
Chief Development Officer |
Sell |
12.5
|
-15,000
|
-23.82%
|
✓
|
$503.9K |
| Oct 29, 2020 |
Nov 2, 2020 |
KalVista Pharmaceuticals, Inc.
|
Chief Development Officer |
Sell |
32.5
|
-5,000
|
-7.36%
|
✓
|
$87.4K |
| Oct 20, 2020 |
Oct 22, 2020 |
KalVista Pharmaceuticals, Inc.
|
Chief Development Officer |
Sell |
20.0
|
-13,986
|
-17.07%
|
✓
|
$249.2K |
| Oct 16, 2020 |
Oct 20, 2020 |
KalVista Pharmaceuticals, Inc.
|
Chief Development Officer |
Sell |
48.8
|
-914
|
-1.10%
|
✓
|
$15.5K |
| Feb 5, 2020 |
Feb 7, 2020 |
KalVista Pharmaceuticals, Inc.
|
Chief Development Officer |
Sell |
55.0
|
-100
|
-0.12%
|
✓
|
$1.7K |
| Dec 20, 2019 |
Dec 26, 2019 |
KalVista Pharmaceuticals, Inc.
|
Chief Development Officer |
Sell |
41.3
|
-2,646
|
-3.09%
|
✓
|
$45K |
| Dec 12, 2019 |
Dec 16, 2019 |
KalVista Pharmaceuticals, Inc.
|
Chief Development Officer |
Sell |
45.0
|
-4,709
|
-1.86%
|
✓
|
$80.3K |
| Jul 22, 2019 |
Jul 24, 2019 |
KalVista Pharmaceuticals, Inc.
|
Chief Development Officer |
Sell |
28.8
|
-7,355
|
-8.14%
|
✓
|
$134.9K |
| Apr 22, 2019 |
Apr 23, 2019 |
KalVista Pharmaceuticals, Inc.
|
Chief Development Officer |
Sell |
28.8
|
-7,355
|
-8.14%
|
✓
|
$191.5K |
| Jan 25, 2019 |
Jan 29, 2019 |
KalVista Pharmaceuticals, Inc.
|
Chief Development Officer |
Sell |
32.5
|
-5,453
|
-6.17%
|
✓
|
$93K |
| Jan 22, 2019 |
Jan 24, 2019 |
KalVista Pharmaceuticals, Inc.
|
Chief Development Officer |
Sell |
48.8
|
-1,902
|
-1.13%
|
✓
|
$32.3K |